Adult Spinal Deformity Market Growth in Future Scope 2023-2030


Spinal deformity is an abnormal alignment or curve of the bony vertebral column. This can occur as a result of aging, injury, previous spine surgery, birth defect, or child growth. In adults, the most common type of spinal deformity is degenerative scoliosis.

The major symptoms of adult spinal deformity include mid-to-lower back, and numbness or weakness in the legs or feet. Not all adults with degenerative scoliosis experience pain.

Key players in the market are focused on growth strategies such as product launch and approval, which is expected to drive the growth of market over forecast period. For instance, In September 2021, SeaSpine Holdings Corporation, a medical technology company focused on surgical solution for spinal disorder has launched mariner adult deformity system pedicle screw for acute and chronic deformities

Moreover, increasing prevalence of degenerative disc disease is expected to support the market growth over the forecast period. For instance, according to the National Center for Biotechnology Information report, around 266 million patients worldwide were diagnosed with lumbar degenerative spine disease (DSD) in 2018.

High cost associated with degenerative disc disease treatments such as artificial disc replacement and spinal fusion is expected to hamper the adult spinal deformity market  growth in the near future. For instance, the average cost of specific disc replacement surgery procedure ranges between US$ 16,000 to US$ 46,000 in different states of the U.S.


Comments

Post a Comment

Popular posts from this blog

Mantle Cell Lymphoma Treatment Market will generate new growth opportunities 2023-2030

Image
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma (NHL) that arises from abnormal B lymphocytes (a type of white blood cell) known as mantle cells. It is considered an aggressive subtype of NHL, and its treatment typically involves a combination of different approaches, including chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. Here is a detailed overview of the treatment options for mantle cell lymphoma : Chemotherapy: Chemotherapy drugs are commonly used as the initial treatment for MCL. The specific chemotherapy regimens may vary, but commonly used combinations include R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high-dose methotrexate and cytarabine), or Bendamustine combined with rituximab (BR). Chemotherapy is typically administered in cycles over several months. Immunotherapy: ...
Read more

Phosphodiesterase Enzyme (PDE) Inhibitors Market 2023 Report Contains Key Vendor Analysis, Vendor Landscape and Forecast to 2030

Image
Phosphodiesterase (PDE) inhibitors are a class of drugs that act on the phosphodiesterase enzymes , specifically the cyclic nucleotide phosphodiesterases. These enzymes are responsible for the degradation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are important intracellular signaling molecules involved in various physiological processes. By inhibiting the activity of PDE enzymes, PDE inhibitors increase the levels of cAMP and cGMP in cells, leading to a variety of pharmacological effects. PDE inhibitors are used to treat a range of conditions, including erectile dysfunction, pulmonary arterial hypertension, and chronic obstructive pulmonary disease. They are available in different formulations, including oral tablets, sublingual tablets, and inhalers. There are several types of PDE enzymes, and PDE inhibitors are classified based on their selectivity for specific PDE enzyme subtypes. The major PDE inhibitors used in clinical practice ...
Read more

Enteral Nutrition Market will generate new growth opportunities 2023-2030

Image
Enteral nutrition is a method of providing nutrition directly into the gastrointestinal tract. It involves the delivery of a liquid formula containing nutrients through a tube, which can be inserted through the nose (nasogastric or nasoenteric tube) or directly into the stomach or small intestine (gastrostomy or jejunostomy tube). Enteral nutrition is typically used when a person is unable to consume an adequate amount of food orally or has a dysfunctional or non-functioning gastrointestinal tract. It may be used in various medical conditions such as: Inability to swallow: Patients who have difficulty swallowing due to conditions like stroke, neurological disorders, or head and neck cancers may require enteral nutrition to ensure adequate nutrition. Gastrointestinal disorders: Individuals with conditions such as Crohn's disease, short bowel syndrome, or malabsorption disorders may have difficulty absorbing nutrients from food, and enteral nutri...
Read more